Literature DB >> 3204412

Abnormalities of the axonal cytoskeleton in giant axonal neuropathy.

M Donaghy1, R H King, P K Thomas, J M Workman.   

Abstract

Intermediate filaments accumulate abnormally in a variety of cell types in individuals with human inherited giant axonal neuropathy (GAN). A characteristic feature of this disorder is the occurrence of focal axonal enlargements filled with accumulations of neurofilaments. The minimum separations between neurofilaments in sural nerve axons of a patient with GAN were 12-30 nm compared with 24-60 nm in controls. The normal sidearm protrusions which cross-bridge adjacent filaments were rare in GAN. Average minimum neurofilament diameter was 12.4 nm in GAN compared with 10.1 nm in controls. Many axons were devoid of neurofilaments and contained an increased density of microtubules, many of which did not run longitudinally. This disorganization of microtubule alignment may reflect the lack of an associated neurofilament lattice. It is concluded that GAN involves abnormalities of neurofilament cross-linkage to one another and to adjacent microtubules. Mechanisms are discussed which could account for this inherited disorder of intermediate filament organization affecting various cell types.

Entities:  

Mesh:

Year:  1988        PMID: 3204412     DOI: 10.1007/bf01674207

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  15 in total

1.  Giant axonal neuropathy: report on a case with focal fiber loss.

Authors:  M Sabatelli; E Bertini; S Servidei; E Fernandez; S Magi; P Tonali
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Neurofilaments switch between distinct mobile and stationary states during their transport along axons.

Authors:  Niraj Trivedi; Peter Jung; Anthony Brown
Journal:  J Neurosci       Date:  2007-01-17       Impact factor: 6.167

Review 3.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

4.  Conformational properties of interacting neurofilaments: Monte Carlo simulations of cylindrically grafted apposing neurofilament brushes.

Authors:  Lakshmi Jayanthi; William Stevenson; Yongkyu Kwak; Rakwoo Chang; Yeshitila Gebremichael
Journal:  J Biol Phys       Date:  2012-12-13       Impact factor: 1.365

Review 5.  Two novel mutations in the GAN gene causing giant axonal neuropathy.

Authors:  Monica Irad Normendez-Martínez; Lucero Monterde-Cruz; Roberto Martínez; Magdalena Marquez-Harper; Nayelli Esquitin-Garduño; Margarita Valdes-Flores; Leonora Casas-Avila; Valeria Ponce de Leon-Suarez; Viktor Javier Romero-Díaz; Alberto Hidalgo-Bravo
Journal:  World J Pediatr       Date:  2018-06-06       Impact factor: 2.764

6.  Giant axonal neuropathy (GAN): an immunohistochemical and ultrastructural study report of a Latin American case.

Authors:  A L Taratuto; G Sevlever; M Saccoliti; L Caceres; M Schultz
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

7.  Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1.

Authors:  Florence Dequen; Pascale Bomont; Geneviève Gowing; Don W Cleveland; Jean-Pierre Julien
Journal:  J Neurochem       Date:  2008-07-31       Impact factor: 5.372

Review 8.  A review of gigaxonin mutations in giant axonal neuropathy (GAN) and cancer.

Authors:  James J Kang; Isabelle Y Liu; Marilene B Wang; Eri S Srivatsan
Journal:  Hum Genet       Date:  2016-03-29       Impact factor: 4.132

9.  The sensory neuropathy of Friedreich's ataxia: an autopsy study of a case with prolonged survival.

Authors:  S Jitpimolmard; J Small; R H King; J Geddes; P Misra; J McLaughlin; J R Muddle; M Cole; A E Harding; P K Thomas
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

10.  Gigaxonin controls vimentin organization through a tubulin chaperone-independent pathway.

Authors:  Don W Cleveland; Koji Yamanaka; Pascale Bomont
Journal:  Hum Mol Genet       Date:  2009-01-24       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.